Duncan Ross - CardieX CEO, Managing Director, Executive Director
CEO
Mr. Duncan R. Ross, BS serves as Managing Director, Executive Director of the Company. He was Chief Executive Officer, Managing Director, Executive Director of AtCor Medical Holdings Limited. He is the Executive director of the Group since November 2006. He has 29 years in life sciences and medical device industry.He is the Most recent Group President of Fisher Scientific Inc and Apogent Technologies Inc prior to joining AtCor Medical. since 2017.
| Age | 55 |
| Tenure | 7 years |
| Phone | 61 2 9874 8761 |
| Web | http://cardiex.com |
CardieX Management Efficiency
The company has return on total asset (ROA) of (16.43) % which means that it has lost $16.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.97) %, meaning that it generated substantial loss on money invested by shareholders. CardieX's management efficiency ratios could be used to measure how well CardieX manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. CardieX Limited has a current ratio of 1.67, which is within standard range for the sector. Debt can assist CardieX until it has trouble settling it off, either with new capital or with free cash flow. So, CardieX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardieX Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardieX to invest in growth at high rates of return. When we think about CardieX's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 4 records | CEO Age | ||
| Vincent Roche | Analog Devices | 64 | |
| Sanjeev Luther | Eterna Therapeutics | 62 | |
| Keith Smith | Boyd Gaming | 63 | |
| Thomas Lingelbach | Valneva SE ADR | 61 | |
Management Performance
| Return On Equity | -48.97 | |||
| Return On Asset | -16.43 |
CardieX Limited Leadership Team
Elected by the shareholders, the CardieX's board of directors comprises two types of representatives: CardieX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardieX. The board's role is to monitor CardieX's management team and ensure that shareholders' interests are well served. CardieX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardieX's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rhonda Welch, Vice President of Global Marketing | ||
| David Brookes, Independent Non-Executive Director | ||
| Mark Harding, VP of Global Marketing and International Sales - Atcor Medical Pty Ltd | ||
| Niall Cairns, Non-Executive Director | ||
| Chris Dax, Vice President - Operations | ||
| Peter Jenkins, Independent Non-Executive Director | ||
| Craig Cooper, CEO, Executive Director | ||
| Duncan Ross, CEO, Managing Director, Executive Director | ||
| Randall Nelson, Independent Non-Executive Director | ||
| Douglas Kurschinski, Sr. VP of Atcor Medical Inc and General Manager of Atcor Medical Inc | ||
| Michael ORourke, Non-Executive Director | ||
| Donal ODwyer, Independent Non-Executive Chairman of the Board | ||
| Peter Manley, CFO, Company Secretary |
CardieX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CardieX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -48.97 | |||
| Return On Asset | -16.43 | |||
| Profit Margin | (61.97) % | |||
| Operating Margin | (48.59) % | |||
| Current Valuation | 32.61 M | |||
| Shares Outstanding | 532.82 M | |||
| Shares Owned By Insiders | 46.84 % | |||
| Price To Earning | (1.47) X | |||
| Price To Book | 5.00 X | |||
| Price To Sales | 4.20 X |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the CardieX Limited information on this page should be used as a complementary analysis to other CardieX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in CardieX OTC Stock
If you are still planning to invest in CardieX Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CardieX's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |